Business · 01/03/2019Updated: 10/17/2026 · 1 min read
FDA to Hold Public Meeting on Rare Diseases, Seeks Public Comments
Summary
The FDA is hosting a public meeting to gather patients' and caregivers' perspectives on the impact of rare diseases on daily life, with the goal of advancing the development of treatments for these conditions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →